S.4003

New Jersey S4003 mandates Medicaid coverage for continuous glucose monitors and related supplies for individuals diagnosed with diabetes who meet.

New Jersey S4003 amends the state's Medicaid program to require coverage for continuous glucose monitors (CGM) and related supplies for individuals diagnosed with diabetes. To be eligible for this coverage, the individual must be treated with insulin or have a history of problematic hypoglycemia, defined as a glucose level below 54 mg/dL (3.0 mmol/L). Specifically, the bill requires documentation of at least two level two hypoglycemic events that persist despite attempts to adjust medications or modify the diabetes treatment plan, or a history of one level three hypoglycemic event that is.